General Cannabis (7A7) Stock Price & Analysis

1 Followers

7A7 Stock Chart & Stats

€0.10€0.00(0.00%)

At close: Nov 09 5:30 PM GMT+1

Day’s Range: EUR 0.10 - EUR 0.10
52-Week Range: EUR 0.10 - EUR 0.10
Previous Close: EUR 0.10
Volume: N/A
Average Volume (3M): 0
Market Cap: EUR 1.66M
Enterprise Value: EUR 23.31T
Total Cash (Recent Filing): EUR 214.33K
Total Debt (Recent Filing): EUR 17.31M
Price to Earnings (P/E): ―
Beta: N/A
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Operating Profitability Improving

EBIT turning positive in 2025 and sustained gross profit demonstrate material improvement in core unit economics. Durable margin recovery reduces cash burn risk, supports reinvestment or debt reduction, and increases the probability that the business can reach sustained profitability if revenue stabilizes.

Narrowing Free Cash Flow Losses

A sharp narrowing of free cash flow shortfalls signals improving cash conversion and operational discipline. Sustained improvement lowers near-term external funding needs, strengthens liquidity dynamics over months, and provides management more flexibility to prioritize deleveraging or targeted growth investments.

Sizeable Asset Base

A sizable asset base offers tangible resources that can support operations, collateralize financings, or be monetized if needed. Over a multi-month horizon this provides options for restructuring capital, securing bridge financing, or extracting value to shore up the balance sheet if operating trends continue improving.

Bears Say

Negative Shareholder Equity

Negative equity is a structural weakness that impairs financial flexibility and increases refinancing risk. It restricts access to conventional capital, can trigger covenant or counterparty issues, and typically forces dilutive issuances or costly debt solutions, affecting long-term solvency and strategy execution.

Contracting Revenue Trend

A multi-year revenue contraction undermines scale economics, reduces operating leverage, and pressures margins despite cost improvements. Persistent top-line declines make it harder to sustain recent EBIT gains and increase the likelihood that profitability gains are temporary without a durable recovery in demand or market share.

Persistent Negative Cash Flow

Ongoing negative operating and free cash flow mean the business remains reliant on external capital to fund operations. This structural cash deficit raises dilution or debt risk, limits strategic optionality, and can force short-term financing decisions that harm long-term shareholder value if negative cash generation persists.

General Cannabis News

DEA judge pauses marijuana rescheduling hearing

DEA Chief Administrative Law Judge Derek Julius on Tuesday issued a stay and pause proceedings in an ongoing hearing on the Trump administration’s marijuana rescheduling proposal in response to a

1M agoACB CGC

Roth views partial cannabis re-scheduling order as ‘extremely favorable’

Roth Capital notes that the DOJ has officially rescheduled cannabis products that are FDA approved and products regulated by state medical programs to Schedule 3 and points out that an

6M agoACB CGC

Trump Trade: Trump officials reclassify state-licensed medical marijuana

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily

6M agoACB CGC

Trump administration reclassifies state-licensed medical marijuana

In accordance with President Trump’s December 18, Executive Order on Increasing Medical Marijuana and Cannabidiol Research, the Justice Department and the Drug Enforcement Administration announced the issuance of an order

6M agoACB CGC

Trump administration expected to reclassify cannabis soon, Axios reports

The Trump administration is expected to move to reclassify cannabis as soon as Wednesday, making it easier to research medicinal applications of the plant, Axios’ Josephine Walker and Marc Caputo

6M agoACB CGC

Congressman introduces bill for cannabis businesses to list on stock exchanges

Representative Guy Rechenthaler is sponsoring a bill to prohibit federal agencies from taking any adverse action against a person solely because the person provides business assistance to a cannabis-related legitimate

7M agoACB CGC

Study says cannabis shows little benefit for mental disorders, Reuters says

According to a large review of studies published in major medical journal The Lancet, cannabis-based medicines show little evidence of effectiveness for treating most mental health and substance-use disorders, Sriparna

7M agoACB CGC

Trump Trade: U.S. delays tariffs on Chinese semiconductors

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily

10M agoMU ACB

Trump orders rescheduling of cannabis by end of January, Marijuana Herald says

President Trump has instructed Attorney General Pam Bondi to finalize a decision on marijuana rescheduling by the end of January, Anthony Martinelli of The Marijuana Herald reported, citing sources close

10M agoACB CGC

Trump Trade: Trump increasing medical marijuana, cannabidiol research

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily

10M agoACB CGC

General Cannabis Completes Acquisition of Beddor Claude LLC

General Cannabis ( ($CANN) ) has shared an announcement. General Cannabis, through its subsidiary Trees Colorado LLC, completed the acquisition of Beddor Claude LLC, a cannabis dispensary and cultivation operation

1y ago8K CANN

General Cannabis Expands and Restructures Leadership

General Cannabis ( ($CANN) ) has shared an announcement. On January 31, 2025, General Cannabis, through Trees Colorado LLC, agreed to acquire Chronic Therapy, a dispensary in Wheat Ridge, Colorado,

1y ago8K CANN

7A7 FAQ

What was General Cannabis’s price range in the past 12 months?

General Cannabis lowest stock price was €0.10 and its highest was €0.10 in the past 12 months.

What is General Cannabis’s market cap?

General Cannabis’s market cap is €1.66M.

When is General Cannabis’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were General Cannabis’s earnings last quarter?

General Cannabis released its earnings results on Aug 08, 2024. The company reported -€0.009 earnings per share for the quarter.

Is General Cannabis overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does General Cannabis pay dividends?

General Cannabis does not currently pay dividends.

What is General Cannabis’s EPS estimate?

General Cannabis’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does General Cannabis have?

General Cannabis has 115,094,250 shares outstanding.

What happened to General Cannabis’s price movement after its last earnings report?

General Cannabis reported an EPS of -€0.009 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of General Cannabis?

Currently, no hedge funds are holding shares in DE:7A7

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description